Key facts
- This page summarizes Robert J. Alpern's Form 4 filing for AbbVie Inc. (ABBV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 May 2025, 17:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).